Riskpilot← Back to searchSign inGet full accessFrogner Heart AB
ABActiveOrg 5591678353Björketorp 474Medical specialists activities · NACE 8622Est. 20183 employees
Revenue 2025
SEK 4,4M
-1% vs 2024
EBITDA margin
21.6%
-12% vs 2024
Equity ratio
58.5%
Financial strength
Net profit 2025
SEK 867K
-5% vs 2024
| Revenue | SEK 4,4M | -1% |
| EBITDA | SEK 957K | -12% |
| Net profit | SEK 867K | -5% |
| Total assets | SEK 1,9M | -5% |
| Equity | SEK 1,1M | +6% |
| Employees | 3 | — |
Legal name
Frogner Heart AB
Org number
5591678353
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
14 augusti 2018
Share capital
SEK 50 000
Employees
3 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sjukvård, värdepappershantering, utbildning inom vård och omsorg.
Address
Björketorp 474
Email
fredrik@frogner.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 3 094 | 4 083 | 3 964 | 4 418 | 4 386 | 4 488 | 4 426 |
| Staff expenses | — | — | — | — | — | — | — |
| EBITDA | 462 | 1 189 | 1 017 | 1 193 | 1 027 | 1 088 | 957 |
| Depreciation & amort. | −132 | −225 | −231 | −231 | −231 | −28 | −6 |
| EBIT | 330 | 964 | 786 | 962 | 796 | 1 060 | 951 |
| Net financials | — | — | — | −2 | −2 | — | — |
| Profit before tax | 113 | 710 | 635 | 748 | 831 | 1 152 | 1 097 |
| Tax | −25 | −152 | −136 | −155 | −174 | −241 | −230 |
| Net profit | 88 | 558 | 499 | 593 | 657 | 911 | 867 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 1 935 | 2 083 | 1 700 | 1 879 | 1 705 | 2 016 | 1 922 |
| Equity | 138 | 697 | 696 | 789 | 747 | 1 058 | 1 124 |
| Long-term debt | 1 476 | 665 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 104 | 252 | 383 | 257 | 163 | 254 | 240 |
| Total debt | 1 580 | 917 | 383 | 257 | 163 | 254 | 240 |
EBITDA margin
21.6%
This company
15.8%
Market median
+37% vs market
20192025
Equity ratio
58.5%
This company
38.2%
Market median
+53% vs market
20192025
Return on equity
77.1%
This company
18.4%
Market median
+319% vs market
20192025
Net profit margin
19.6%
This company
8.1%
Market median
+142% vs market
20192025
Asset turnover
2.30×
This company
1.12×
Market median
+105% vs market
20192025
Debt / equity
0.71×
This company
0.62×
Market median
+15% vs market
20192025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-08-01 – 2019-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MW | Audit | 2022 | — | — |
LA Audit | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Frogner Heart AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marcus Wallentin Torstensson | Audit | 0 companies |
| Lars Anders Karlsson | Audit | 0 companies |
| Emma Kristina Frogner | Deputy Board Member | 0 companies |
| Jan Fredrik Frogner | Board of Directors | 0 companies |